↓ Skip to main content

Dove Medical Press

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia

Overview of attention for article published in OncoTargets and therapy, March 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
patent
1 patent

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
123 Mendeley
Title
Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
Published in
OncoTargets and therapy, March 2017
DOI 10.2147/ott.s106810
Pubmed ID
Authors

Jamie Koprivnikar, James McCloskey, Stefan Faderl

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 123 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 14%
Researcher 15 12%
Student > Ph. D. Student 15 12%
Student > Bachelor 15 12%
Other 12 10%
Other 22 18%
Unknown 27 22%
Readers by discipline Count As %
Medicine and Dentistry 38 31%
Biochemistry, Genetics and Molecular Biology 23 19%
Agricultural and Biological Sciences 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 7%
Nursing and Health Professions 2 2%
Other 11 9%
Unknown 30 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2023.
All research outputs
#3,416,577
of 25,382,440 outputs
Outputs from OncoTargets and therapy
#119
of 3,016 outputs
Outputs of similar age
#60,442
of 324,443 outputs
Outputs of similar age from OncoTargets and therapy
#5
of 91 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,443 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.